RESEARCH ON COVID-19 IN THE WAKE OF SARS-COV-2 OUTBREAK
Deadline: 11 May 2020
Budget: Modules 1, 2, 3: up to 2 million euros per project; Module 4: up to 50,000 euros per project
Description: Funding will be provided for individual projects and, exceptionally, small research consortia (up to 3 partners). Funding will also be provided for individual projects by German applicants who wish to participate in international research consortia within the framework of the global research response to COVID-19 coordinated by the WHO. The funding covers a period of 18 months; the BMBF intends to share relevant data with international sponsors who are WHO-coordinated in GloPID-R. Funded projects must be application-oriented research and development: projects relying mainly on basic research are not eligible for funding. Cooperation with thematically related R&D projects abroad is possible, although the international partner(s) must in principle have their own funding for their part(s) of the project. However, if cooperation with a foreign working group is necessary for the processing of an essential work package, personnel and material resources in the form of a subcontract are eligible for funding.
The call is composed of four modules:
- Module 1 - Combating COVID-19 through early clinical studies for the application of already known therapeutic approaches to Sars-CoV-2;
- Module 2 - Control of COVID-19 through new therapeutic and diagnostic approaches;
- Module 3 - Research that contributes to the understanding of the virus and its spread;
- Module 4 - Support of already ongoing research projects on coronaviruses.
This call is open to Chinese participation